Profound Medical PROF Ratios (2018-2026)

NASDAQ PROF
$5.79 +0.07 (+1.22%)
As of: Sep 30, 2026 · 2:34 PM EDT
Reported Financials

Profound Medical Quarterly Ratios

Periods 17 quarters
Latest Jun 2026

Profound Medical reported a gross margin of 78.41% and a net margin of -384.21% for the quarter ended Jun 2026. These financial ratios cover 17 quarters of results from Dec 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Ratios Dec2018 Jan2019 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Profitability
Gross Margin 60.18%63.64%63.14%70.93%70.70%73.18%74.32%66.77%71.80%78.41%
EBT Margin -454.83%-309.00%-324.44%-124.16%-407.59%-706.97%-148.53%-136.34%-131.68%-382.00%
EBIT Margin -547.39%-351.19%-317.73%-199.83%-426.02%-624.42%-168.52%-123.29%-150.29%-445.67%
EBITDA Margin -530.02%-340.71%-310.17%-194.13%-419.80%-618.05%-165.74%-121.47%-148.42%-440.23%
Operating Margin -547.39%-351.19%-317.73%-199.83%-426.02%-624.42%-168.52%-123.29%-150.29%-445.67%
Net Margin -457.61%-309.85%-330.69%1,213.72%409.16%-709.86%-150.82%1,287.69%-132.15%-384.21%
FCF Margin -314.73%-278.50%-241.03%-140.78%-316.02%-621.62%-181.77%-109.85%-160.82%-456.63%
Efficiency
Inventory AverageInventory Avg. 2.71M3.14M4.47M6.37M7.68M7.46M6.30M7.57M8.35M8.29M8.62M9.73M
Assets AverageAssets Avg. 34.70M31.85M67.09M95.69M75.60M54.19M65.55M55.27M45.99M59.89M75.47M67.92M
Equity AverageEquity Avg. 19.85M16.83M55.74M88.98M66.61M41.91M38.37M42.21M34.81M45.57M55.61M45.02M35.70M49.29M62.93M54.62M
Invested CapitalInvested Cap. 29.23M28.28M23.13M59.77M38.33M65.08M55.28M43.72M36.62M70.93M63.93M54.31M
Asset Utilization RatioAsset Util. 0.180.210.310.270.250.28
Leverage & Solvency
Debt Ratio 0.260.260.300.110.160.070.070.090.110.060.060.07
Valuation
Price to EarningsP/E 6.693.884.883.913.725.094.64
Price to SalesP/S 17.4114.7514.9810.3314.7812.5212.73
Price to BookP/B 9.184.272.894.325.814.555.276.363.083.444.524.593.583.964.88
Enterprise Value 115.23M331.58M166.16M180.86M155.22M207.24M205.06M195.30M131.08M128.48M142.12M122.82M178.21M185.17M204.67M
Market Capitalization 129.79M415.50M233.32M227.38M181.44M207.24M205.06M195.30M185.99M174.91M177.31M147.65M237.93M235.47M242.94M
Return Ratios
Return on Sales [ROS]ROS -547.39%-351.19%-317.73%-199.83%-426.02%-624.42%-168.52%-123.29%-150.29%-445.67%
Return on Capital Employed [ROCE]ROCE -60.33%-85.41%-117.15%-76.66%-58.76%-60.14%
Return on Invested Capital [ROIC]ROIC -60.40%-85.49%-105.09%-76.71%-56.52%-59.82%
Return on Assets [ROA]ROA -48.75%-73.70%-85.55%-71.08%-51.55%-48.21%
Return on Equity [ROE]ROE -61.04%-57.47%-90.46%-110.20%-86.37%-61.82%-59.95%

Profound Medical Ratios API

Pull Profound Medical's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=PROF&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEY